Brind.

CEO of VIR Biotechnology participated in a conference chat hosted by Morgan Stanley on August 26, 2025.

1 report, 1 independent Updated Aug 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

Morgan Stanley VIR Biotechnology

Keep exploring

The entities involved

Morgan Stanley
U.S. investment bank
- Financial firms including Morgan Stanley, Truist Financial, Jefferies Financial Group, and CIBC issued rating and price objective updates for Clearway Energy.Mon 17:33
- Goldman Sachs, Morgan Stanley, JPMorgan Chase, and Bank of America are competing in the global investment banking sector.Mon 17:24
VIR Biotechnology
biotech company

Nothing else this week.

Coverage

Newest first; wire copies grouped

Aug 26Business WireVir Biotechnology to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference SAN FRANCISCO, August 25, 2025--(BUSINESS WIRE)--Vir Biotechnology, Inc. (Nasdaq: VIR) today announced